Patents Assigned to APSE, INC.
  • Publication number: 20220145294
    Abstract: The invention provides methods and compositions for improved production of large quantities of unencapsidated double strand RNA (dsRNA) in vivo. The disclosed methods and compositions, comprising co-expression of genes encoding orotate phosporibosyl transferase, bacteriophage coat protein and dsRNA produce a significant improvement over current in vivo methods of producing unencapsidated dsRNA.
    Type: Application
    Filed: July 7, 2020
    Publication date: May 12, 2022
    Applicant: APSE, INC.
    Inventors: John L. KILLMER, Patrick D. McLAUGHLIN, Juan Pedro Humberto ARHANCET
  • Publication number: 20210127683
    Abstract: The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications.
    Type: Application
    Filed: October 20, 2020
    Publication date: May 6, 2021
    Applicant: APSE, INC.
    Inventors: John L. Killmer, Juan Pedro Humberto Arhancet, Patrick D. McLaughlin
  • Patent number: 10806150
    Abstract: The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications. Specifically, the disclosure provides a method for controlling target insects comprising, transforming a microbial host with a first DNA sequence comprising a gene encoding a bacteriophage capsid protein and a second DNA sequence encoding an RNA transcript comprising at least one bacteriophage pac sequence coupled to an RNAi precursor sequence, inducing the microbial host to express the first and second DNA sequences, isolating virus-like-particles (VLPs) comprising the capsid protein and RNAi precursor from the microbial host, and contacting the isolated VLPs with the target insects.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: October 20, 2020
    Assignee: APSE, INC.
    Inventors: John L. Killmer, Juan Pedro Humberto Arhancet, Patrick D. McLaughlin
  • Patent number: 10704045
    Abstract: Methods and materials for improved in vivo production of dsRNA are presented. Yields of dsRNA are significantly increased in the presence of capsid protein. The improved yield of dsRNA is not dependent on the presence of specific cognate binding sites for capsid protein associated with the dsRNA, but is dependent on capsid protein.
    Type: Grant
    Filed: March 9, 2017
    Date of Patent: July 7, 2020
    Assignee: APSE, INC.
    Inventors: John L. Killmer, Patrick D. McLaughlin, Juan Pedro Humberto Arhancet
  • Patent number: 10428329
    Abstract: Novel processes and compositions are described which use viral capsid proteins resistant to hydrolases to prepare virus-like particles to enclose and subsequently isolate and purify target cargo molecules of interest including nucleic acids such as siRNAs and shRNAs, miRNAs, messenger RNAs, small peptides and bioactive molecules.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: October 1, 2019
    Assignee: APSE, INC.
    Inventors: Juan Pedro Humberto Arhancet, Juan P. Arhancet, Kimberly Delaney, Kathleen B. Hall, Neena Summers, Edward Oates
  • Publication number: 20190093108
    Abstract: Methods and materials for improved in vivo production of dsRNA are presented. Yields of dsRNA are significantly increased in the presence of capsid protein. The improved yield of dsRNA is not dependent on the presence of specific cognate binding sites for capsid protein associated with the dsRNA, but is dependent on capsid protein.
    Type: Application
    Filed: March 9, 2017
    Publication date: March 28, 2019
    Applicant: APSE, INC.
    Inventors: John L. KILLMER, Patrick D. McLAUGHLIN, Juan Pedro Humberto ARHANCET
  • Publication number: 20190029265
    Abstract: The invention describes recombinant sequences and methods for producing RNAs suitable for controlling proliferation of ant species, including Solenopsis, Camponotus, Linepithema, Tapinoma, Tetramorium, and Monomorium spp.
    Type: Application
    Filed: January 31, 2017
    Publication date: January 31, 2019
    Applicant: APSE, INC.
    Inventors: John L. KILLMER, Anil KUMAR, Patrick D. McLAUGHLIN, Juan Pedro Humberto ARHANCET
  • Publication number: 20180368422
    Abstract: The invention describes recombinant DNA sequences transcribed into RNA constructs capable of forming Virus Like Particles (VLPs) suitable for insect control applications. Specifically, the disclosure provides a method for controlling target insects comprising, transforming a microbial host with a first DNA sequence comprising a gene encoding a bacteriophage capsid protein and a second DNA sequence encoding an RNA transcript comprising at least one bacteriophage pac sequence coupled to an RNAi precursor sequence, inducing the microbial host to express the first and second DNA sequences, isolating virus-like-particles (VLPs) comprising the capsid protein and RNAi precursor from the microbial host, and contacting the isolated VLPs with the target insects.
    Type: Application
    Filed: December 7, 2016
    Publication date: December 27, 2018
    Applicant: APSE, INC.
    Inventors: John L. Killmer, Juan Pedro Humberto Arhancet, Patrick D. McLaughlin
  • Publication number: 20180030445
    Abstract: Novel processes and compositions are described which use viral capsid proteins resistant to hydrolases to prepare virus-like particles to enclose and subsequently isolate and purify target cargo molecules of interest including nucleic acids such as siRNAs and shRNAs, miRNAs, messenger RNAs, small peptides and bioactive molecules.
    Type: Application
    Filed: October 17, 2017
    Publication date: February 1, 2018
    Applicant: APSE, INC.
    Inventors: Juan Pedro Humberto ARHANCET, JUAN P. ARHANCET, Kimberly DELANEY, Kathleen B. HALL, Neena SUMMERS, Edward OATES
  • Patent number: 9822361
    Abstract: Novel processes and compositions are described which use viral capsid proteins resistant to hydrolases to prepare virus-like particles to enclose and subsequently isolate and purify target cargo molecules of interest including nucleic acids such as siRNAs and shRNAs, miRNAs, messenger RNAs, small peptides and bioactive molecules.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: November 21, 2017
    Assignee: APSE, INC.
    Inventors: Juan Pedro Humberto Arhancet, Juan P. Arhancet, Kimberly Delaney, Kathleen B. Hall, Neena Summers, Edward Oates